University of Roma La Sapienza: Coronary Artery Disease trials
The registry lists 32 Coronary Artery Disease studies with University of Roma La Sapienza as lead sponsor. 2 are open to participants now and 0 have results posted.
Phase 3 3Phase 4 19No phase 10(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Prospective muLticEnter Registry in chrONic coronARy synDrOmeNot yet recruitingNCT06198673
- Sex-related Differences in Outcome After Hybrid Coronary RevascularizationNot yet recruitingNCT06023355
- Anticoagulation on Demand After Percutaneous Coronary Intervention in High Bleeding Risk PatientsStatus unknownNCT04151680
- One Versus Twice Daily Administration of Multiple Cardiovascular Agents in Patients With Ischemic Heart DiseaseStatus unknownNCT04148820Phase 4
- Atherectomy vs Intravascular LithotripsyStatus unknownNCT04013906Not applicable
- Low Dose Statins, Ezetimibe and NutraceuticalsStatus unknownNCT03277079Phase 4
- Biofreedom Stent in All Comer PopulationCompletedNCT02858739
- Sex and Gender Differences in Ischemic Heart Disease - Endocrine Vascular Disease ApproachCompletedNCT02737982
- Coronary Angiography Before Elective Carotid Endarterectomy in Patients With Asymptomatic Coronary Artery DiseaseCompletedNCT02260453Phase 3
- Role of the Inflammatory Receptors in the Pathogenesis of AtherosclerosisStatus unknownNCT02062216
- "Potential Effect of Acute and Chronic Caffeine Administration on Platelet Reactivity in Patient With Coronary Artery Disease on Dual Antiplatelet Therapy"Status unknownNCT02054988Not applicable
- Pharmacodynamic Comparison of Rosuvastatin Versus Atorvastatin on Platelet Reactivity in Patients With Coronary Artery Disease on Dual Antiplatelet Therapy With New P2Y12 Inhibitors (Trial gRANADa)Status unknownNCT02030054Phase 4
- "Pharmacodynamic Comparison of Omeprazole Versus Pantoprazole on Platelet Reactivity in Patients With Acute Coronary Syndromes on Dual Antiplatelet Therapy With New P2Y12 Inhibitors" -Trial dOPPLER-Status unknownNCT02028234Phase 4
- Potential Impact of Cigarette Smoking on Platelet Reactivity in Patients on Dual Antiplatelet Therapy With P2Y12 InhibitorsStatus unknownNCT02026713Phase 4
- Low-dose Statins and Nutraceuticals in High-intensity Statin-intolerant PatientsStatus unknownNCT02001883Phase 4
- Effects of a rapamycIn-eluting carboNized Stent With a Completely biodEgradable polymeR CoatingStatus unknownNCT01981304
- Cholesterol-lowering Effects of nutraceuticaLs Versus Ezetimibe in Statin-intolerant PatientsStatus unknownNCT01807078Phase 4
- Fenoldopam for Prevention of Acute Kidney InjuryStatus unknownNCT01690832Phase 4
- PharmacOdynamic compaRison of piTavastatin Versus atOrvastatin on Platelet ReactivityStatus unknownNCT01648829Phase 4
- Thalidomide fOr the Prevention of Restenosis After Coronary ArtERy Stent ImplantationStatus unknownNCT01638078Phase 4
- Progenitor Cells Role in Restenosis and AtherosclerosisCompletedNCT01575431
- Local Thrombolytics Before Thrombectomy in STEMIStatus unknownNCT01568931Phase 4
- Pharmacodynamic Effects of Atorvastatin vs. Rosuvastatin on Platelet ReactivityStatus unknownNCT01567774Phase 4
- Bivalirudin Plus Stenting in Long Lesion to Avoid Periprocedural Myocardial Necrosis TrialStatus unknownNCT01555658Phase 3
- High Clopidogrel Dose Versus Prasugrel and Ticagrelor in High Reactive Stable PatientsCompletedNCT01543932Phase 3
- Ranolazine for Improving Symptoms of PalpitationsStatus unknownNCT01495520Phase 4
- N-GAL Allows Intensive Treatment of Contrast Induced NephropathyStatus unknownNCT01491243Phase 4
- Ranolazine Loading to Prevent PCI-induced Myocardial InjuryStatus unknownNCT01491061Phase 4
- Pharmacodynamic Effects of Ranolazine Versus Amlodipine on Platelet ReactivityStatus unknownNCT01490255Phase 4
- Ezetimibe Versus Nutraceuticals in Statin-intolerant PatientsStatus unknownNCT01490229Phase 4
- Effects of DES Platforms on Markers of Endothelial Damage and InflammationStatus unknownNCT01489202Phase 4
- Aspirin Reload Before Percutaneous Coronary Intervention: Reperfusion Indexes Evaluation.CompletedNCT01374698Phase 4